Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Neoplasms 3Small Cell Lung Carcinoma 2Recurrence 2Lymphoma 2Non-Erosive Reflux Disease 1Melanoma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Hematologic Neoplasms 1Gastrointestinal Hemorrhage 1Gastroesophageal Reflux 1Dyspepsia 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Barrett Esophagus 1Atrophy 1Advanced Solid Tumors 1Advanced Solid Malignancies 1Adenocarcinoma 1Acrocephalosyndactylia 1

Interventions

Endoscopy, Digestive System 4Esomeprazole 3Biopsy 3YF 476 2Specimen Handling 2Proton Pump Inhibitors 2Lansoprazole 2Endoscopy 2plecanatide 1omeprazole, sodium bicarbonate drug combination 1linaclotide 1ilaprazole 1Surveys and Questionnaires 1Rabeprazole 1Proflavine 1Lysine Acetyltransferase 5 1Gastropexy 1Gastroenterostomy 1Gastric Bypass 1Fundoplication 1Fluorescein 1Endoscopic Mucosal Resection 1Endoscopes 1Diet, Gluten-Free 1Dexlansoprazole 1Anastomosis, Roux-en-Y 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastroesophageal Reflux × Rabeprazole × Clear all
NCT02149914 2014-11-20

The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients

Taichung Tzu Chi Hospital

Phase NA Unknown
120 enrolled
Gastrointestinal

Non-Erosive Reflux Disease, Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡